Trials / Completed
CompletedNCT06053541
Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change
Hospitalization, Mortality Rates and Costs Associated With Chronic Obstructive Pulmonary Disease (COPD) in Distrito Federal, Brazil, Before and After the Change in 2018 State COPD Protocol Version - Real-world Data
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,015,000 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates hospitalizations and mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) before and after the implantation of a new COPD treatment plan (replacement of tiotropium soft mist inhaler for glycopyrronium dry powder inhaler) by the Health State Secretariat of Federal District in Brazil.
Conditions
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2023-09-25
- Last updated
- 2024-10-26
- Results posted
- 2024-10-26
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06053541. Inclusion in this directory is not an endorsement.